Amgen CEO Bradway On Deals: Good (Smaller) Opportunities Are Vast
J.P. Morgan Q&A Illuminates Market Dynamics
Amgen is enthusiastic about deals of all sizes, including a new Arrakis collaboration, and is interested in large transactions like its Otezla buy – but Bradway said right-priced opportunities are fewer and farther between.